Review



human tumor cell lines a549  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human tumor cell lines a549
    (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on <t>A549</t> cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.
    Human Tumor Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 35713 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tumor cell lines a549/product/ATCC
    Average 99 stars, based on 35713 article reviews
    human tumor cell lines a549 - by Bioz Stars, 2026-04
    99/100 stars

    Images

    1) Product Images from "Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms"

    Article Title: Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms

    Journal: bioRxiv

    doi: 10.64898/2026.03.06.710085

    (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on A549 cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.
    Figure Legend Snippet: (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on A549 cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.

    Techniques Used: Transformation Assay, Derivative Assay, Clone Assay, Plasmid Preparation, Purification, Microscopy, Infection, Transfection, Isolation, Sequencing

    (A) Brightfield microscopy images of plaque assays performed on HeLa cells infected with parental viruses (VACV, CPXV, RPXV) and with chimeric viruses rescued from TAR-shuffling clones (cPOX01-02, cPOX02-03, cPOX04-12, cPOX05-14, and cPOX06-18). HeLa cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification. (B) Representative comet-shaped plaques observed in A549 cells. A549 monolayers were infected with the indicated viruses, incubated for 48 h, and stained with crystal violet to visualize comet formation, reflecting enhanced viral spread
    Figure Legend Snippet: (A) Brightfield microscopy images of plaque assays performed on HeLa cells infected with parental viruses (VACV, CPXV, RPXV) and with chimeric viruses rescued from TAR-shuffling clones (cPOX01-02, cPOX02-03, cPOX04-12, cPOX05-14, and cPOX06-18). HeLa cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification. (B) Representative comet-shaped plaques observed in A549 cells. A549 monolayers were infected with the indicated viruses, incubated for 48 h, and stained with crystal violet to visualize comet formation, reflecting enhanced viral spread

    Techniques Used: Microscopy, Infection, Clone Assay, Incubation, Staining

    (A–D) A549 (A), HCT 116 (B), HeLa (C), and MIA PaCa-2 (D) cells were infected with serial dilutions of each virus. Cell viability was assessed 4 days post-infection using the CellTiter-Blue assay and normalized to uninfected controls. Data represent the mean ± SD from three independent experiments. (E) EC₅₀ values for each virus in each cell line were calculated by fitting a sigmoidal dose–response curve to the viability data shown in panels A–D. Statistical significance was determined relative to the VACV group using one-way ANOVA: p < 0.05 (*).
    Figure Legend Snippet: (A–D) A549 (A), HCT 116 (B), HeLa (C), and MIA PaCa-2 (D) cells were infected with serial dilutions of each virus. Cell viability was assessed 4 days post-infection using the CellTiter-Blue assay and normalized to uninfected controls. Data represent the mean ± SD from three independent experiments. (E) EC₅₀ values for each virus in each cell line were calculated by fitting a sigmoidal dose–response curve to the viability data shown in panels A–D. Statistical significance was determined relative to the VACV group using one-way ANOVA: p < 0.05 (*).

    Techniques Used: Infection, Virus, CtB Assay

    (A) Viral amplification in A549 cells. Monolayers were infected at a MOI of 10⁻³. At 3 days post-infection, both supernatants and cells were collected, and viral progeny were quantified by plaque assay. Results are expressed as fold amplification, calculated as the output/input ratio. Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**). (B) Ratio of EEV to total progeny virus (IMV + EEV). A549 cell monolayers were infected with the indicated viruses at a MOI of 0.1. Viral titers were determined for EEV (supernatant only) and total progeny virus (IMV + EEV; combined supernatants and cells). Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**).
    Figure Legend Snippet: (A) Viral amplification in A549 cells. Monolayers were infected at a MOI of 10⁻³. At 3 days post-infection, both supernatants and cells were collected, and viral progeny were quantified by plaque assay. Results are expressed as fold amplification, calculated as the output/input ratio. Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**). (B) Ratio of EEV to total progeny virus (IMV + EEV). A549 cell monolayers were infected with the indicated viruses at a MOI of 0.1. Viral titers were determined for EEV (supernatant only) and total progeny virus (IMV + EEV; combined supernatants and cells). Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**).

    Techniques Used: Amplification, Infection, Plaque Assay, Virus



    Similar Products

    99
    ATCC human tumor cell lines a549
    (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on <t>A549</t> cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.
    Human Tumor Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tumor cell lines a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    human tumor cell lines a549 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC human lung tumor cell line a549
    (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on <t>A549</t> cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.
    Human Lung Tumor Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung tumor cell line a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    human lung tumor cell line a549 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC human lung tumor derived cell line a549
    Effect of compounds 11a and 11b on the protein expression of the Gli1 transcription factor and its transcriptional targets in <t>A549</t> (A) and DU145 (B) cells following 24 h of incubation. An antibody against GAPDH was used as an internal loading control.
    Human Lung Tumor Derived Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung tumor derived cell line a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    human lung tumor derived cell line a549 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC human tumor adenocarcinoma cell line a549
    ( A ) EPN3 expression level between normal tissue and lung <t>Adenocarcinoma.</t> ( B ) Prognosis of LUAD patients between high EPN3 expression level group and low EPN3 expression level group. ( C ) EPN3 expression level between normal lung cell line (Beas-2B) and lung cancer cell <t>line(A549</t> and H1299) by western blot. n = 3, p < 0.05. Quantification of bands relative to β-actin using Graphpad prism (*p < 0.05; **p < 0.005).
    Human Tumor Adenocarcinoma Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tumor adenocarcinoma cell line a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    human tumor adenocarcinoma cell line a549 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC a549 human lung tumor cell line
    ( A ) EPN3 expression level between normal tissue and lung <t>Adenocarcinoma.</t> ( B ) Prognosis of LUAD patients between high EPN3 expression level group and low EPN3 expression level group. ( C ) EPN3 expression level between normal lung cell line (Beas-2B) and lung cancer cell <t>line(A549</t> and H1299) by western blot. n = 3, p < 0.05. Quantification of bands relative to β-actin using Graphpad prism (*p < 0.05; **p < 0.005).
    A549 Human Lung Tumor Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 human lung tumor cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    a549 human lung tumor cell line - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    90
    Informa UK Limited human tumor cell lines (mcf-7, u87, hct116 and a549)
    ( A ) EPN3 expression level between normal tissue and lung <t>Adenocarcinoma.</t> ( B ) Prognosis of LUAD patients between high EPN3 expression level group and low EPN3 expression level group. ( C ) EPN3 expression level between normal lung cell line (Beas-2B) and lung cancer cell <t>line(A549</t> and H1299) by western blot. n = 3, p < 0.05. Quantification of bands relative to β-actin using Graphpad prism (*p < 0.05; **p < 0.005).
    Human Tumor Cell Lines (Mcf 7, U87, Hct116 And A549), supplied by Informa UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tumor cell lines (mcf-7, u87, hct116 and a549)/product/Informa UK Limited
    Average 90 stars, based on 1 article reviews
    human tumor cell lines (mcf-7, u87, hct116 and a549) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on A549 cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.

    Journal: bioRxiv

    Article Title: Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms

    doi: 10.64898/2026.03.06.710085

    Figure Lengend Snippet: (A) PCR analysis of the three VACV genomic fragments transformed into yeast, performed on pre-selected TAR-derived clones. (B) Restriction enzyme analysis of plasmid DNA from clones C1 and C2 following transformation into E. coli and plasmid purification. (C) Brightfield microscopy images of plaque assays on A549 cells infected with MVA, VACV, the rescue material from cells transfected with pYCC3-VACV_C1 (clone C1), the rescue material from cells transfected with pYCC3-VACV_C2 (clone C2), as well as rescue samples from MVA-infected cells transfected with pYCC3-VACV_C1 (MVA + pYCC3-VACV_C1) or pYCC3-VACV_C2 (MVA + pYCC3-VACV_C2). A549 cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification using brightfield microscopy. (D) Distribution of parental viral genomes within isolated clones obtained from rescue experiments in MVA-infected cells transfected with pYCC3-VACV_C1 or pYCC3-VACV_C2, based on deep sequencing analysis.

    Article Snippet: Human tumor cell lines A549 (ATCC CCL-185), HeLa (ATCC CCL-2), MIA-PaCa-2 (ATCC CRL-1420), HCT116 (ATCC CCL-247), and the African green monkey kidney cell line Vero (ATCC CCL-81) were maintained at 37 °C in a humidified atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA) or McCoy’s 5A medium (LGC Standards, UK), supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA) and 100 μg·mL−1 gentamycin (Sigma-Aldrich, USA).

    Techniques: Transformation Assay, Derivative Assay, Clone Assay, Plasmid Preparation, Purification, Microscopy, Infection, Transfection, Isolation, Sequencing

    (A) Brightfield microscopy images of plaque assays performed on HeLa cells infected with parental viruses (VACV, CPXV, RPXV) and with chimeric viruses rescued from TAR-shuffling clones (cPOX01-02, cPOX02-03, cPOX04-12, cPOX05-14, and cPOX06-18). HeLa cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification. (B) Representative comet-shaped plaques observed in A549 cells. A549 monolayers were infected with the indicated viruses, incubated for 48 h, and stained with crystal violet to visualize comet formation, reflecting enhanced viral spread

    Journal: bioRxiv

    Article Title: Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms

    doi: 10.64898/2026.03.06.710085

    Figure Lengend Snippet: (A) Brightfield microscopy images of plaque assays performed on HeLa cells infected with parental viruses (VACV, CPXV, RPXV) and with chimeric viruses rescued from TAR-shuffling clones (cPOX01-02, cPOX02-03, cPOX04-12, cPOX05-14, and cPOX06-18). HeLa cells were seeded at 5 × 10⁵ cells per well in 6-well plates and infected at a multiplicity of infection (MOI) of 10⁻⁵. Images were acquired 48 h post-infection at 4× magnification. (B) Representative comet-shaped plaques observed in A549 cells. A549 monolayers were infected with the indicated viruses, incubated for 48 h, and stained with crystal violet to visualize comet formation, reflecting enhanced viral spread

    Article Snippet: Human tumor cell lines A549 (ATCC CCL-185), HeLa (ATCC CCL-2), MIA-PaCa-2 (ATCC CRL-1420), HCT116 (ATCC CCL-247), and the African green monkey kidney cell line Vero (ATCC CCL-81) were maintained at 37 °C in a humidified atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA) or McCoy’s 5A medium (LGC Standards, UK), supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA) and 100 μg·mL−1 gentamycin (Sigma-Aldrich, USA).

    Techniques: Microscopy, Infection, Clone Assay, Incubation, Staining

    (A–D) A549 (A), HCT 116 (B), HeLa (C), and MIA PaCa-2 (D) cells were infected with serial dilutions of each virus. Cell viability was assessed 4 days post-infection using the CellTiter-Blue assay and normalized to uninfected controls. Data represent the mean ± SD from three independent experiments. (E) EC₅₀ values for each virus in each cell line were calculated by fitting a sigmoidal dose–response curve to the viability data shown in panels A–D. Statistical significance was determined relative to the VACV group using one-way ANOVA: p < 0.05 (*).

    Journal: bioRxiv

    Article Title: Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms

    doi: 10.64898/2026.03.06.710085

    Figure Lengend Snippet: (A–D) A549 (A), HCT 116 (B), HeLa (C), and MIA PaCa-2 (D) cells were infected with serial dilutions of each virus. Cell viability was assessed 4 days post-infection using the CellTiter-Blue assay and normalized to uninfected controls. Data represent the mean ± SD from three independent experiments. (E) EC₅₀ values for each virus in each cell line were calculated by fitting a sigmoidal dose–response curve to the viability data shown in panels A–D. Statistical significance was determined relative to the VACV group using one-way ANOVA: p < 0.05 (*).

    Article Snippet: Human tumor cell lines A549 (ATCC CCL-185), HeLa (ATCC CCL-2), MIA-PaCa-2 (ATCC CRL-1420), HCT116 (ATCC CCL-247), and the African green monkey kidney cell line Vero (ATCC CCL-81) were maintained at 37 °C in a humidified atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA) or McCoy’s 5A medium (LGC Standards, UK), supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA) and 100 μg·mL−1 gentamycin (Sigma-Aldrich, USA).

    Techniques: Infection, Virus, CtB Assay

    (A) Viral amplification in A549 cells. Monolayers were infected at a MOI of 10⁻³. At 3 days post-infection, both supernatants and cells were collected, and viral progeny were quantified by plaque assay. Results are expressed as fold amplification, calculated as the output/input ratio. Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**). (B) Ratio of EEV to total progeny virus (IMV + EEV). A549 cell monolayers were infected with the indicated viruses at a MOI of 0.1. Viral titers were determined for EEV (supernatant only) and total progeny virus (IMV + EEV; combined supernatants and cells). Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**).

    Journal: bioRxiv

    Article Title: Synthetic Genome Shuffling of Poxviruses through Yeast for Next-Generation Oncolytic Platforms

    doi: 10.64898/2026.03.06.710085

    Figure Lengend Snippet: (A) Viral amplification in A549 cells. Monolayers were infected at a MOI of 10⁻³. At 3 days post-infection, both supernatants and cells were collected, and viral progeny were quantified by plaque assay. Results are expressed as fold amplification, calculated as the output/input ratio. Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**). (B) Ratio of EEV to total progeny virus (IMV + EEV). A549 cell monolayers were infected with the indicated viruses at a MOI of 0.1. Viral titers were determined for EEV (supernatant only) and total progeny virus (IMV + EEV; combined supernatants and cells). Data represent mean ± SD from three independent experiments. Statistical significance was assessed against the VACV group using one-way ANOVA: not significant (ns), p < 0.05 (*), p < 0.01 (**).

    Article Snippet: Human tumor cell lines A549 (ATCC CCL-185), HeLa (ATCC CCL-2), MIA-PaCa-2 (ATCC CRL-1420), HCT116 (ATCC CCL-247), and the African green monkey kidney cell line Vero (ATCC CCL-81) were maintained at 37 °C in a humidified atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA) or McCoy’s 5A medium (LGC Standards, UK), supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA) and 100 μg·mL−1 gentamycin (Sigma-Aldrich, USA).

    Techniques: Amplification, Infection, Plaque Assay, Virus

    Effect of compounds 11a and 11b on the protein expression of the Gli1 transcription factor and its transcriptional targets in A549 (A) and DU145 (B) cells following 24 h of incubation. An antibody against GAPDH was used as an internal loading control.

    Journal: ACS Omega

    Article Title: Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells

    doi: 10.1021/acsomega.4c11479

    Figure Lengend Snippet: Effect of compounds 11a and 11b on the protein expression of the Gli1 transcription factor and its transcriptional targets in A549 (A) and DU145 (B) cells following 24 h of incubation. An antibody against GAPDH was used as an internal loading control.

    Article Snippet: The human lung tumor-derived cell line A549 was obtained from ATCC and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% FBS.

    Techniques: Expressing, Incubation, Control

    ( A ) EPN3 expression level between normal tissue and lung Adenocarcinoma. ( B ) Prognosis of LUAD patients between high EPN3 expression level group and low EPN3 expression level group. ( C ) EPN3 expression level between normal lung cell line (Beas-2B) and lung cancer cell line(A549 and H1299) by western blot. n = 3, p < 0.05. Quantification of bands relative to β-actin using Graphpad prism (*p < 0.05; **p < 0.005).

    Journal: Scientific Reports

    Article Title: Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial–mesenchymal transition

    doi: 10.1038/s41598-024-68193-1

    Figure Lengend Snippet: ( A ) EPN3 expression level between normal tissue and lung Adenocarcinoma. ( B ) Prognosis of LUAD patients between high EPN3 expression level group and low EPN3 expression level group. ( C ) EPN3 expression level between normal lung cell line (Beas-2B) and lung cancer cell line(A549 and H1299) by western blot. n = 3, p < 0.05. Quantification of bands relative to β-actin using Graphpad prism (*p < 0.05; **p < 0.005).

    Article Snippet: The human normal bronchial cell line Beas-2b, human tumor adenocarcinoma cell line A549 and human non-small cell lung carcinoma cell line H1299 were purchased from ATCC (Manassas, VA, USA).

    Techniques: Expressing, Western Blot

    Western blot analysis of EPN3-knockdown (KD) cell lines and expression of EMT markers. The differences in expression level of EPN3 between normal cell, control group and EPN3-KD group in A549 and H1299 ( A , B ). The differences in expression level of NCAD, ECAD and VIM between control group and EPN3-KD group in A549 ( C , E , G ). The differences in expression level of NCAD, ECAD and VIM between control group and EPN3-KD group in H1299 ( D , F , H ). NCAD, N-cadherin; ECAD, E-cadherin; VIM, vimentin. n = 3, *p < 0.05, **p < 0.01, ***p < 0.001.

    Journal: Scientific Reports

    Article Title: Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial–mesenchymal transition

    doi: 10.1038/s41598-024-68193-1

    Figure Lengend Snippet: Western blot analysis of EPN3-knockdown (KD) cell lines and expression of EMT markers. The differences in expression level of EPN3 between normal cell, control group and EPN3-KD group in A549 and H1299 ( A , B ). The differences in expression level of NCAD, ECAD and VIM between control group and EPN3-KD group in A549 ( C , E , G ). The differences in expression level of NCAD, ECAD and VIM between control group and EPN3-KD group in H1299 ( D , F , H ). NCAD, N-cadherin; ECAD, E-cadherin; VIM, vimentin. n = 3, *p < 0.05, **p < 0.01, ***p < 0.001.

    Article Snippet: The human normal bronchial cell line Beas-2b, human tumor adenocarcinoma cell line A549 and human non-small cell lung carcinoma cell line H1299 were purchased from ATCC (Manassas, VA, USA).

    Techniques: Western Blot, Knockdown, Expressing, Control

    Effects of EPN3-KD on cell migration using the indicated cell lines. The wound healing assays results and statistical analysis of A549 cell line ( A , B ). The wound healing assays results and statistical analysis of H1299 cell line ( C , D ). n = 3,*p < 0.05, ***p < 0.001.

    Journal: Scientific Reports

    Article Title: Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial–mesenchymal transition

    doi: 10.1038/s41598-024-68193-1

    Figure Lengend Snippet: Effects of EPN3-KD on cell migration using the indicated cell lines. The wound healing assays results and statistical analysis of A549 cell line ( A , B ). The wound healing assays results and statistical analysis of H1299 cell line ( C , D ). n = 3,*p < 0.05, ***p < 0.001.

    Article Snippet: The human normal bronchial cell line Beas-2b, human tumor adenocarcinoma cell line A549 and human non-small cell lung carcinoma cell line H1299 were purchased from ATCC (Manassas, VA, USA).

    Techniques: Migration

    Crystal violet staining and quantification of EPN3-KD cell invasion experiment in Transwell plates and statistical analysis for the A549 and H1299 cell lines ( A ). Migration experiment in Transwell plates and statistical analysis for the A549 and H1299. n = 3, **p < 0.01.

    Journal: Scientific Reports

    Article Title: Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial–mesenchymal transition

    doi: 10.1038/s41598-024-68193-1

    Figure Lengend Snippet: Crystal violet staining and quantification of EPN3-KD cell invasion experiment in Transwell plates and statistical analysis for the A549 and H1299 cell lines ( A ). Migration experiment in Transwell plates and statistical analysis for the A549 and H1299. n = 3, **p < 0.01.

    Article Snippet: The human normal bronchial cell line Beas-2b, human tumor adenocarcinoma cell line A549 and human non-small cell lung carcinoma cell line H1299 were purchased from ATCC (Manassas, VA, USA).

    Techniques: Staining, Migration

    Western blot analysis of protein expression of key EMT-related factors in EPN3-KD cell line. The differences in expression level of ZEB1, β-catenin and Snail between control group and EPN3-KD group in A549 ( A ). The differences in expression level of ZEB1, β-catenin and Snail between control group and EPN3-KD group in H1299 ( B ). n = 3, *p < 0.05, **p < 0.01.

    Journal: Scientific Reports

    Article Title: Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial–mesenchymal transition

    doi: 10.1038/s41598-024-68193-1

    Figure Lengend Snippet: Western blot analysis of protein expression of key EMT-related factors in EPN3-KD cell line. The differences in expression level of ZEB1, β-catenin and Snail between control group and EPN3-KD group in A549 ( A ). The differences in expression level of ZEB1, β-catenin and Snail between control group and EPN3-KD group in H1299 ( B ). n = 3, *p < 0.05, **p < 0.01.

    Article Snippet: The human normal bronchial cell line Beas-2b, human tumor adenocarcinoma cell line A549 and human non-small cell lung carcinoma cell line H1299 were purchased from ATCC (Manassas, VA, USA).

    Techniques: Western Blot, Expressing, Control